Relationship of ENOS and RAS gene polymorphisms to initial peritoneal transport status in peritoneal dialysis patients

Nephron - Clinical Practice

Volumn 104, Issue 1, 2006, Pages

  Akcay, Ali ^a,b   Micozkadioglu, Hasan ^a   Atac, Fatma Belgin ^a   Agca, Erhan ^a   Ozdemir, Fatma Nurhan ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b Oguzlar Mahallesi   (Turkey)

Author keywords

Angiotensin II type 1 receptor; Angiotensin II type 2 receptor; Angiotensin converting enzyme; Angiotensinogen; Endothelial nitric oxide synthase; Gene polymorphisms; Nitric oxide; Peritoneal dialysis; Peritoneal transport type; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; RENIN;

ADULT; ARTICLE; BLOOD VESSEL PERMEABILITY; DEMOGRAPHY; DISEASE ASSOCIATION; ENOS GENE; FEMALE; FLUID BALANCE; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; ONCOGENE RAS; PERITONEAL DIALYSIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; BIOLOGICAL TRANSPORT; FEMALE; GENOTYPE; HUMANS; KIDNEY DISEASES; MALE; NITRIC OXIDE SYNTHASE TYPE III; PERITONEAL DIALYSIS; PERITONEUM; PERMEABILITY; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM;

EID: 33747322764     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093669     Document Type: Article

References (31)

1. Krediet RT: The peritoneal membrane in chronic peritoneal dialysis. Kidney Int 1999;55:341-356.
2. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT; Peritoneal Biopsy Study Group: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002;13:470-479.
3. Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramirez-Huesca M, Dominguez-Jimenez C, Jimenez-Heffernan JA, Aguilera A, Sanchez-Tomero JA, Bajo MA, Alvarez V, Castro MA, del Peso G, Cirujeda A, Gamallo C, Sanchez-Madrid F, Lopez-Cabrera M: Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003;348:403-413.
4. Wang T, Heimburger O, Waniewski J, Bergstrom J, Lindholm B: Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 1998;13:1242-1249.
5. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998;9:1285-1292.
6. Cueto-Manzano AM, Correa-Rotter R: Is high peritoneal transport rate an independent risk factor for CAPD mortality? Kidney Int 2000;57:314-320.
7. Szeto CC, Law MC, Wong TY, Leung CB, Li PK: Peritoneal transport status correlates with morbidity but not longitudinal change of nutritional status of continuous ambulatory peritoneal dialysis patients: a 2-year prospective study. Am J Kidney Dis 2001;37:329-336.
8. Ishani A, Raij L: Hypertension, nitric oxide and end-organ damage. Curr Opin Nephrol Hypertens 1999;8:237-241.
9. Leclercq B, Jaimes EA, Raij L: Nitric oxide synthase and hypertension. Curr Opin Nephrol Hypertens 2002;11:185-189.
10. Devuyst O, Nielsen S, Cosyns JP, Smith BL, Agre P, Squifflet JP, Pouthier D, Goffin E: Aquaporin-1 and endothelial nitric oxide synthase expression in capillary endothelia of human peritoneum. Am J Physiol 1998;275(1 Pt 2):H234-H242.
11. Combet S, Van Landschoot M, Moulin P, Piech A, Verbavatz JM, Goffin E, Balligand TL, Lameire N, Devuyst O: Regulation of aquaporin-1 and nitric oxide synthase isoforms in a rat model of acute peritonitis. T Am Soc Nephrol 1999;10:2185-2196.
12. Combet S, Miyata T, Moulin P, Pouthier D, Goffin E, Devuyst O: Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol 2000;11:717-728.
13. Ferrier ML, Combet S, van Landschoot M, Stoenoiu MS, Cnops Y, Lameire N, Devuyst O: Inhibition of nitric oxide synthase reverses changes in peritoneal permeability in a rat model of acute peritonitis. Kidney Int 2001;60:2343-2350.
14. Ni T, Moulin P, Gianello P, Feron O, Balligand JL, Devuyst O: Mice that lack endothelial nitric oxide synthase are protected against functional and structural modifications induced by acute peritonitis. J Am Soc Nephrol 2003;14:3205-3216.
15. Douma CE, de Waart DR, Struijk DG, Krediet RT: The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD. Kidney Int 1997;51:1885-1892.
16. Breborowicz A, Wieczorowska-Tobis K, Korybalska K, Polubinska A, Radkowski M, Oreo-poulos DG: The effect of a nitric oxide inhibitor (L-NAME) on peritoneal transport during dialysis in rats. Perit Dial Int 1998;18:188-192.
17. Rumpsfeld M, McDonald SP, Purdie DM, Collins J, Johnson DW: Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients. Am J Kidney Dis 2004;43:492-501.
18. Mujais S, Vonesh E: Profiling of peritoneal ultrafiltration. Kidney Int 2002;62(suppl 81): S17-S22.
19. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346.
20. Lalouel JM, Rohrwasser A, Terreros D, Morgan T, Ward K: Angiotensinogen in essential hypertension: from genetics to nephrology. J Am Soc Nephrol 2001;12:606-615.
21. Abdi R, Huong TTB, Zee R, Brenner BM, Milford EL: Angiotensin gene polymorphism as a determinant of posttransplantation renal dysfunction and hypertension. Transplantation 2001;72:726-729.
22. Lovati E, Richard A, Frey BM, Frey FJ, Ferrari P: Genetic polymorphisms of the reninangiotensin-aldosterone system in end stage renal disease. Kidney Int 2001;60:46-54.
23. Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A, Kawaguchi Y, Hosoya T, Igari J: Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 1998;245:190-193.
24. Thomas S, Bruce C, Birkhead A, Wang L: Effect of ecNOS polymorphisms and coronary artery disease upon exhaled nitric oxide. J Mol Med 2002;80:181-186.
25. Twardowski ZJ, Nolph KD, Prowant B, Ryan L, Moore H, Nielsen MP: Peritoneal equilibration test. Perit Dial Bull 1987;7:138-147.
26. Bilsborough W, Green DJ, Mamotte CD, van Bockxmeer FM, O'Driscoll GJ, Taylor RR: Endothelial nitric oxide synthase gene polymorphism, homocysteine, cholesterol and vascular endothelial function. Atherosclerosis 2003;169:131-138.
27. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL, Jain RK: Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 2001;98:2604-2609.
28. Asakimori Y, Yorioka N, Tanaka J, Kohno N: Effect of polymorphism of the endothelial nitric oxide synthase and apolipoprotein E genes on carotid atherosclerosis in hemodialysis patients. Am J Kidney Dis 2003;41:822-832.
29. Noiri E, Satoh H, Taguchi J, Brodsky SV, Nakao A, Ogawa Y, Nishijima S, Yokomizo T, Tokunaga K, Fujita T: Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 2002;40:535-540.
30. Wong TY, Szeto CC, Szeto CY, Lai KB, Chow KM, Li PK: Association of ENOS polymorphism with basal peritoneal membrane function in uremic patients. Am J Kidney Dis 2003;42:781-786.
31. Gillerot G, Goffin E, Michel C, Evenepoel P, Biesen WV, Tintillier M, Stenvinkel P, Heimburger O, Lindholm B, Nordfors L, Robert A, Devuyst O: Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. Kidney Int 2005;67:2477-2487.